Showing results (591-600 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|July 27, 2012
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?Kieron Dunleavy, Cliona Grant, Franziska C Eberle, et al.Current Hematologic Malignancy Reports|February 10, 2015
A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient populationSabarinath Venniyil Radhakrishnan, Gerhard C HildebrandtCurrent Hematologic Malignancy Reports|May 17, 2023
Pelabresib (CPI-0610): An Exciting Novel Drug for the Treatment of MyelofibrosisGuadalupe Ferreira Gomes, Claire HarrisonCurrent Hematologic Malignancy Reports|February 15, 2023
CML Outcomes and Care Delivery During the COVID-19 Pandemic in Low- and Middle-Income CountriesMika Matsuzaki, Alicia Annamalay, Pat Garcia-Gonzalez, et al.Current Hematologic Malignancy Reports|August 1, 2016
Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for YouMarco Ruella, Carl H JuneCurrent Hematologic Malignancy Reports|August 1, 2016
What Is the Optimal Induction Therapy for Younger Fit Patients With AML?Hugo F FernandezCurrent Hematologic Malignancy Reports|August 10, 2016
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical AdvancesLynda M Vrooman, Lewis B SilvermanCurrent Hematologic Malignancy Reports|July 15, 2015
Where Does Lenalidomide Fit in Non-del(5q) MDS?Aristoteles GiagounidisCurrent Hematologic Malignancy Reports|July 1, 2015
Chronic Myelomonocytic Leukemia: a Genetic and Clinical UpdateKristen B McCullough, Mrinal M PatnaikCurrent Hematologic Malignancy Reports|July 1, 2015
Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?Anna PorwitPageof 86